C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New Investment in DaVita Inc. (NYSE:DVA)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of DaVita Inc. (NYSE:DVA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 3,994 shares of the company’s stock, valued at approximately $597,000.

Several other institutional investors have also recently made changes to their positions in DVA. Transcendent Capital Group LLC purchased a new stake in DaVita during the third quarter valued at approximately $25,000. Blue Trust Inc. increased its stake in shares of DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after purchasing an additional 119 shares in the last quarter. Quarry LP bought a new position in DaVita in the 3rd quarter worth $60,000. Venturi Wealth Management LLC lifted its position in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after purchasing an additional 152 shares in the last quarter. Finally, Versant Capital Management Inc grew its holdings in DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the period. Institutional investors own 90.12% of the company’s stock.

Analysts Set New Price Targets

Separately, Barclays raised their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $162.80.

DaVita Stock Down 0.1 %

DVA opened at $154.84 on Thursday. The stock has a market cap of $12.39 billion, a price-to-earnings ratio of 14.42, a price-to-earnings-growth ratio of 0.79 and a beta of 0.94. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The firm’s fifty day moving average is $161.40 and its 200 day moving average is $157.89. DaVita Inc. has a fifty-two week low of $119.42 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, sell-side analysts forecast that DaVita Inc. will post 10.93 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.